1 / 11

Aflatoxin B1

Aflatoxin B1. Aflatoxin B1: Background. Hepatotoxic mycotoxin produced by the fungi Aspergillus flavus and Aspergillus parasiticus Causes aflatoxicosis and liver disease

Télécharger la présentation

Aflatoxin B1

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.


Presentation Transcript

  1. Aflatoxin B1

  2. Aflatoxin B1: Background • Hepatotoxic mycotoxin produced by the fungi Aspergillus flavus and Aspergillus parasiticus • Causes aflatoxicosis and liver disease • Aspergillus spp. grow ubiquitously on plants and crops from tropical and subtropical areas: peanuts, figs, spices, corn, maize, Brazil nuts, pecans, walnuts, soybeans, pistachios, wheat and grains • The carcinogenic metabolite of Aflatoxin B1 is found in the milk of mammals who consume contaminated crops • Aspergillus growth and Aflatoxin B1 production is dependant upon the temperature, humidity, host plant type, and the strain of fungus; high humidity usually required for growth • Outbreaks more common in developing countries due to improper drying and storage of crops and a lack of food inspections

  3. Background • Outbreaks occur in groups because of a shared contaminated food supply and the optimal weather conditions for Aspergillus growth • First recorded outbreak was in England in 1960, where 100000 turkeys died. • In 1974 in clustered villages in India, 397 recorded cases with 108 deaths; this was preceded by an outbreak in the local dogs • In Kenya in 2004, maize contaminated with Aflatoxin B1 caused liver disease and jaundice in 317 people; 125 people died • The use of antifungal agents is often too costly for farmers in developing countries

  4. Toxicity Parameters • Exposure to 2-6 mg of aflatoxin by consumption daily for one month is cited to have toxic effects (David et al. 1994) • Consumption of 55 µg/ kg of aflatoxin daily for an unknown period of time will be fatal (FDA 1992) • However, levels found to be toxic are inconsistent between various studies. Reasons for this include the fact that most studies were done in African countries where prevalence of Heptatitis B is very high. Active HepB virus is known to be synergistic with aflatoxin in causing toxicities and hepatocellular carcinoma. • As well, most studies were done on rats, which are much more susceptible to the toxin and its metabolites, and thus these studies cannot be extrapolated to humans. • There is a double standard for accepted aflatoxin levels due to economic stress, where food intended for human cconsumption must have less than 30ppb, and animal feed may be as high as 30ppb in America

  5. Mechanism of Action • AFB1 is oxidized by CYT P450 in the liver into AFB1-8,9-epoxide which is the major metabolite that exerts hepatotoxic effects • The 8,9 epoxide is neutralized by conjugation in the liver with GSH (glutathione) by glutathione-S-transferase, an enzyme abundant in some animals (mice), but which rats and humans are relatively deficient in. • The 8,9 epoxide binds preferentially to mitochondrial DNA hindering ATP production and FAD/NAD-linked enzymatic functions. The result is reduced mitochondrial function and increased prevalence of mitochondrial directed apoptosis • GSH has many roles in membrane maintenance and stability as well as reducing oxidative stress. Its reduction further enhances the damage to critical cellular components (DNA, lipids, proteins) by the 8,9 epoxides • Abnormally high levels of ROS are found in cells affected by aflatoxin due to uncoupling of metabolic processes resulting from the lack of GSH for GSH-peroxidase catalysis of O2· to H2O2 leading to lipid peroxidation and compromised cell membranes

  6. AFB1-8,9-epoxide Is Cancer-causing!! • One of the most serious effects of the AFB1-8,9-epoxide metabolite is it reacts with amino acids in DNA and forms an adduct. This adduct is fairly resistant to DNA repair processes and thus this gene mutation may cause carcinoma of the liver. • CYP 3A4 is the major CYP 450 enzyme responsible for activation of AFB1 into the epoxide form. • - However, the liver can detoxify AFB1 by oxidizing it to other metabolites such as AFQ1 which has very little cancer-causing potential. These are usually excreted in urine with little effect on the body. (Novoa and Diaz 2006)

  7. What Exactly Does Aflatoxin Do? • Inactivation of p53 tumor suppressor gene enables mutation of Codon 249 (primary gene mutation caused specifically by AFB1). This shuts off the gene and potentially allows for uncontrolled cell proliferation. • But exposure to aflatoxin does not necessarily predispose you to liver cancer. The human body is capable of genetic repairs and there are differences in carcinogenic susceptibility among individuals in a population.

  8. In general, the incidence of toxicity and cancer is quite low after toxin exposure. The liver is very efficient in removing it from the body in most cases. Children are more susceptible to toxicity because their metabolic enzyme systems are not fully developed.

  9. Other Adverse Effects of AFB1-8,9-epoxide • Lipid accumulation in the liver due to decreased lipid transport and reduced oxidation which in turn reduces lipid synthesis (formation of membranes, etc.) • Jaundice, ascites (fluid build up), portal hypertension, and other symptoms of liver failure occur with acute aflatoxicosis • Both metabolized and unmetabolized aflatoxin is excreted mostly in urine. It is also excreted in milk, stool, feces, and saliva (which may be swallowed and re-enter the GI tract)

  10. Treatment • Inactivation of toxin before ingestion • Synergistic combination of gamma radiation and hydrogen peroxide degrades the toxin • Treatment of corn with ammonia • Dichlorvos inhibits aflatoxin B1 biosynthesis • NaHSO3 soak for corn also shows beneficial results • After ingestion • Treatment with antibiotics or other drugs has little effect • UV doses increased rate and extent of removal of aflatoxin B12 adducts from DNA • Chlorophyll intervention: supplement diets with foods rich in chlorophyll • Blocks carcinogen bioavailability • Certain types of flavanoids found in grapefruit stimulates the microsomal activation of aflatoxin B1 to the exo-8,9-epoxide which is not harmful • Administration of drugs that induce hepatic detoxification enzymes (ethoxyquin, butylated hydroxyanisol, butylated hydroxytuluene, phenobarbital) • Oltipraz inhibits aflatoxin B1 mediated hepatocarcinogens in rats • Induction of an antibody that would allow the body to identify and remove the toxin upon exposure (aflatoxin B1- lysine adduct monoclonal antibody)

  11. Literature Cited • Urrego Novoa JR and Diaz GJ. 2006. Aflatoxins and its mechanisms of toxicity in hepatic cancer. Rev.fac.med.unal. 54: 108-116. Available from World Wide Web: <http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0120-00112006000200006&lng=en&nrm=iso>. • Eaton DL and Gallagher EP. 1994. Mechanism of aflatoxin carcinogenesis. Annual review of pharmacology and toxicology 34: 135-172. • U.S. Food And Drug Administration. “Bad Bug Book: Alfatoxins”. June 14, 2006. <http://www.cfsan.fda.gov/~mow/chap41.html> • Center For Disease Control. Morbidity and Mortality Weekly Report. “Outbreak of Aflatoxin Poisoning - Eastern and Central Provinces, Kenya, January-July 2004”. Sept. 3, 2004. <http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5334a4.htm> • Reddy, S.V., Waliyar, Farid. “Properties of aflatoxin and it producing fungi”. Oct. 11, 2007. http://www.icrisat.org/aflatoxin/aflatoxin.asp • R. J. Verma. 2004. Aflatoxin Cause DNA Damage. International Journal of Human Genetics 4(4): 231-236. • J. H. Williams, et al. 2004. Human aflatoxicosis in developing countries: a review of toxicology, exposure, potential health consequences, and interventions. The American Journal of Clinical Nutrition. 80:1106 –22

More Related